According to a new market report published by Lucintel, the future of the genomic market looks promising with opportunities in the research centers, academic and government institutes, hospitals and clinics, and pharmaceutical and biotechnology companies. The global genomic market is expected to grow with a CAGR of 10% from 2019 to 2024. The major drivers for this market are increasing government funding and growth in the number of genomic projects, decreasing sequencing costs, growing application areas of genomic, and entry of new players and start-ups in the genomic market.
In this market, instruments/systems, consumables, and services are the major product and services segment of genomic. On the basis of comprehensive research, consumables will remain the largest segment. Services is expected to witness highest growth over the forecast period due to growing number of genomic services start-up.
With in the genomics market, diagnostics, drug discovery and development, precision medicine, and agriculture and animal research are the major applications. Diagnostics will remain the largest market and it is also expected to witness the highest growth in the forecast period.
North America will remain the largest market over the forecast period due to increasing research funding and government initiatives in genomic.
Illumina, Agilent Technologies, Thermo Fisher Scientific, Eurofins Scientific, Qiagen, GE Healthcare, F. Hoffmann-La Roche, Oxford Nanopore Technologies, Bio-Rad Laboratories, BGI, Eppendorf, Pacific Biosciences, and Danaher are among the major manufacturers of genomic market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global genomic market by product and services, technology, application, end user, and region. Lucintel has prepared a comprehensive research report entitled "Global Genomic Market 2019-2024: Trends, Forecast, and Opportunity Analysis". This Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the global genomic market by product and services, technology, application, end user, and region as follows:
By Product and Services [$M shipment analysis for 2013 – 2024]:
Instruments/Systems
Consumables
Services
By Technology [$M shipment analysis for 2013 – 2024]:
Sequencing
Microarray
PCR (Polymerase Chain Reaction)
Nucleic Acid Extraction and Purification
Library Preparation
Data Analysis
Other Technologies
By Application [$M shipment analysis for 2013 – 2024]:
Diagnostics
Drug Discovery and Development
Precision Medicine
Agriculture and Animal Research
Other applications
By End User [$M shipment analysis for 2013 – 2024]:
Research Centers, Academic and Government Institutes
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Other End User
By Region [$M shipment analysis for 2013 – 2024]:
United States
Canada
Mexico
United kingdom
Germany
France
Italy
Spain
This research report of more than 150 pages will enable you to make confident
business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link…… or helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.